Myconolak (Amorolfine Hydrochloride)

Amorolfine Hydrochloride inhibits two key enzymes in the ergosterol synthesis pathway of fungi—Δ14‑reductase and Δ7‑Δ8‑isomerase. By blocking these steps, the drug prevents the formation of ergosterol, an essential component of fungal cell membranes, leading to accumulation of toxic sterol intermediates, membrane disruption, and ultimately fungal cell death.

The dosing regimen for Myconolak is determined by the prescribing healthcare professional based on the type and severity of the infection. Typically, the product is applied once daily to the affected area after cleaning and drying the skin or nail, but exact frequency and duration should follow the prescriber's instructions.

Safety data for Amorolfine Hydrochloride in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Myconolak. The prescriber will decide whether the medication is appropriate in each individual case.

To place an order, submit an enquiry on the Myconolak product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details (including any cold‑chain requirements if applicable), and assists with import documentation.

Myconolak (Amorolfine) differs from many other topical antifungals such as ciclopirox or terbinafine by targeting two separate steps in the ergosterol pathway, which can result in a broader spectrum of activity against dermatophytes and yeasts. Clinical experience suggests comparable efficacy for nail infections, with a convenient once‑daily application, but individual response may vary and should be assessed by a clinician.

Store Myconolak at room temperature, ideally below 25 °C (77 °F). Keep the product in its original packaging, protect it from direct sunlight, moisture, and extreme temperatures. Ensure the container is tightly closed when not in use to maintain product stability.

Myconolak is applied topically to the affected nail or skin area. Before each application, clean the site with mild soap and water, dry thoroughly, and then apply a thin layer of the solution or lacquer as directed by the prescriber. Avoid covering the treated area with occlusive dressings unless instructed otherwise.

While most reactions are mild, serious adverse events can include allergic contact dermatitis, severe skin irritation or ulceration, and secondary bacterial infection of the treated area. If any of these occur, discontinue use immediately and seek medical attention. Rare systemic toxicity has been reported only with extensive over‑use.

Myconolak should not be used by individuals with a known hypersensitivity to Amorolfine Hydrochloride or any of the product’s excipients. It is also contraindicated on severely broken, inflamed, or infected skin where the barrier is compromised. Children and adolescents should only use the product if specifically prescribed by a qualified healthcare professional.